Demant A/S (OTCMKTS:WILYY) Stock Rating Cut to Hold at Zacks Research

Demant A/S (OTCMKTS:WILYY) was downgraded by research analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Monday, Zacks reports.

Several other equities analysts also recently issued reports on WILYY. UBS Group lowered shares of Demant A/S from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 22nd. Sanford C. Bernstein lowered shares of Demant A/S from a “strong-buy” rating to a “hold” rating in a report on Friday, July 17th. Finally, Morgan Stanley raised shares of Demant A/S from an “equal weight” rating to an “overweight” rating in a research report on Tuesday, June 23rd. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

Demant A/S Price Performance

OTCMKTS WILYY opened at $24.80 on Monday. The firm’s fifty day moving average price is $23.16 and its two-hundred day moving average price is $20.08. Demant A/S has a fifty-two week low of $13.45 and a fifty-two week high of $24.80.

Demant A/S Company Profile

Demant A/S is a Denmark-based hearing healthcare company that develops, manufactures and distributes products and services designed to help people with hearing loss and other communication needs. The company serves consumers and hearing care professionals through activities spanning hearing aids, diagnostic equipment, hearing care services and specialized communications technology.

Its portfolio includes hearing aids and related software, audiological diagnostic instruments, and technologies used by hearing care professionals to assess and manage hearing conditions.